July 16, 2014
Ono President Gyo Sagara Ono Pharmaceutical will deploy its 30 oncology sales representatives to promote its newly approved Opdivo (recombinant nivolumab), a treatment for unresectable malignant melanoma, with the hopes that it will grow into a best-selling drug. “We are...read more